Wondfo Biotech's US unit gains FDA clearance for flu tests

Wondfo USA obtained FDA 510(k) clearance for its WELLlife Flu A&B Home Test and professional-use version. Both products detect and differentiate influenza A and B viruses from nasal samples within four days of symptom onset.

The home test is the first of its kind to receive FDA approval in the US.